Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. (Q47311801)

13 January 2018

meta-analysis

0 references

title

Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. (English)

1 reference

13 January 2018

1 reference

2

1 reference

13 January 2018

Saroj Niraula

object named as

Saroj Niraula

series ordinal

1

0 references

Pamela J Goodwin

object named as

Pamela J Goodwin

series ordinal

4

0 references

author name string

Marguerite Ennis

series ordinal

3

1 reference

13 January 2018

language of work or name

English

0 references

publication date

5 May 2012

1 reference

13 January 2018

Breast Cancer Research and Treatment

published in

1 reference

13 January 2018

volume

134

1 reference

13 January 2018

page(s)

769-781

1 reference

13 January 2018

issue

2

1 reference

13 January 2018

https://scigraph.springernature.com/pub.10.1007/s10549-012-2073-x

exact match

0 references

cites work

Global burden of obesity in 2005 and projections to 2030.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Central obesity and breast cancer risk: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Is body mass index the prognostic factor in breast cancer?: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Advanced methods in meta-analysis: multivariate approach and meta-regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Obesity and weight change in relation to breast cancer survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Effect of obesity and other lifestyle factors on mortality in women with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen Receptor-Positive Early-Stage Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Obesity and outcomes in premenopausal and postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

BMI influences prognosis following surgery and adjuvant chemotherapy for lymph node positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Weekly paclitaxel in the adjuvant treatment of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Body size, reproductive factors, and breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Body mass index and mortality in women: follow-up of the Canadian National Breast Screening Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Weight, weight gain, and survival after breast cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Risk factors for the incidence of breast cancer: do they affect survival from the disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Waist-to-hip ratio and breast cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Weight gain prior to diagnosis and survival from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Prognostic value of body mass index in locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Body size and survival in premenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

The effect of dietary exposures on recurrence and mortality in early stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

An examination of obesity and breast cancer survival in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Inflammatory breast cancer in Tunisia in the era of multimodality therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Season of tumour detection influences factors predicting survival of patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Underweight and breast cancer recurrence and death: a report from the Korean Breast Cancer Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Diet and risk for breast cancer recurrence and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Is leptin a mediator of adverse prognostic effects of obesity in breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Associations of insulin resistance and adiponectin with mortality in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Metabolic profile, physical activity, and mortality in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Insulin and insulin-like growth factor signalling in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Spurious precision? Meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Prognostic significance of breast relapse after conservative treatment in node-negative early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Obesity and cancer: Pathophysiological and biological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

Conducting Meta-Analyses in R with the metafor Package

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2073-X

10.1007/S10549-012-2073-X

21 January 2018

Identifiers

DOI

1 reference

13 January 2018

PubMed ID

22562122

1 reference

13 January 2018